Literature DB >> 1733441

Ras p21 in breast tissue: associations with pathology and cellular localisation.

J J Going1, T J Anderson, A H Wyllie.   

Abstract

Immunocytochemistry with monoclonal antibody Y13-259 demonstrated p21 ras in paraffin sections of breast tissue from 171 women: 85 with invasive breast carcinoma, 14 with non-invasive carcinoma and 72 with benign changes only. Many different tissue elements contributed to ras expression. Semiquantitative assessment showed that intensity of immunostaining in the normal epithelium of large ducts, small extralobular ducts and terminal duct lobular units (TDLU) was usually exceeded by that of myoepithelial cells. Vascular smooth muscle and apocrine epithelium also stained strongly, but the flat epithelial cells lining cysts did not express detectable p21 ras. There was a progressive increase from normal epithelium through epithelial hyperplasia of usual type and atypical hyperplasia to carcinoma in situ, without further increase in invasive carcinoma. Expression in carcinomas was inversely related to oestrogen receptor content but independent of the prognosis-associated variables of size, histological type, vascular invasion or lymph node metastasis.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1733441      PMCID: PMC1977366          DOI: 10.1038/bjc.1992.9

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


  57 in total

1.  Structure of the human and murine R-ras genes, novel genes closely related to ras proto-oncogenes.

Authors:  D G Lowe; D J Capon; E Delwart; A Y Sakaguchi; S L Naylor; D V Goeddel
Journal:  Cell       Date:  1987-01-16       Impact factor: 41.582

2.  ras proteins can induce meiosis in Xenopus oocytes.

Authors:  C Birchmeier; D Broek; M Wigler
Journal:  Cell       Date:  1985-12       Impact factor: 41.582

3.  Monoclonal antibody Y13-259 recognizes an epitope of the p21 ras molecule not directly involved in the GTP-binding activity of the protein.

Authors:  J C Lacal; S A Aaronson
Journal:  Mol Cell Biol       Date:  1986-04       Impact factor: 4.272

4.  Immunohistochemical detection of ras oncogene p21 product in benign and malignant mammary tissue in man.

Authors:  A K Ghosh; M Moore; M Harris
Journal:  J Clin Pathol       Date:  1986-04       Impact factor: 3.411

5.  Requirement for ras proto-oncogene function during serum-stimulated growth of NIH 3T3 cells.

Authors:  L S Mulcahy; M R Smith; D W Stacey
Journal:  Nature       Date:  1985 Jan 17-23       Impact factor: 49.962

6.  Immunocytochemical demonstration and significance of p21 ras family oncogene product in benign and malignant breast disease.

Authors:  W Candlish; I B Kerr; H W Simpson
Journal:  J Pathol       Date:  1986-11       Impact factor: 7.996

7.  Optimal preservation of p21 ras immunoreactivity and morphology in paraffin-embedded tissue.

Authors:  J J Going; A R Williams; A H Wyllie; T J Anderson; J Piris
Journal:  J Pathol       Date:  1988-07       Impact factor: 7.996

8.  Expression of p21ras in fresh primary and metastatic human colorectal tumors.

Authors:  G E Gallick; R Kurzrock; W S Kloetzer; R B Arlinghaus; J U Gutterman
Journal:  Proc Natl Acad Sci U S A       Date:  1985-03       Impact factor: 11.205

9.  Amplified expression of p21 ras protein in hormone-dependent mammary carcinomas of humans and rodents.

Authors:  M E DeBortoli; H Abou-Issa; B E Haley; Y S Cho-Chung
Journal:  Biochem Biophys Res Commun       Date:  1985-03-15       Impact factor: 3.575

10.  Immunohistochemical detection of the ras oncogene p21 product in an experimental tumour and in human colorectal neoplasms.

Authors:  A R Williams; J Piris; D A Spandidos; A H Wyllie
Journal:  Br J Cancer       Date:  1985-11       Impact factor: 7.640

View more
  10 in total

Review 1.  Apoptosis and the regulation of cell numbers in normal and neoplastic tissues: an overview.

Authors:  A H Wyllie
Journal:  Cancer Metastasis Rev       Date:  1992-09       Impact factor: 9.264

Review 2.  Genomic Changes in Normal Breast Tissue in Women at Normal Risk or at High Risk for Breast Cancer.

Authors:  David N Danforth
Journal:  Breast Cancer (Auckl)       Date:  2016-08-17

3.  High corn oil and extra virgin olive oil diets and experimental mammary carcinogenesis: clinicopathological and immunohistochemical p21Ha-Ras expression study.

Authors:  Irmgard Costa; Raquel Moral; Montserrat Solanas; Francisco Javier Andreu; Maria Carmen Ruiz de Villa; Eduard Escrich
Journal:  Virchows Arch       Date:  2011-01-15       Impact factor: 4.064

4.  Mutations of Ki-ras and p53 genes in colorectal cancer and their prognostic significance.

Authors:  M Morrin; M Kelly; N Barrett; P Delaney
Journal:  Gut       Date:  1994-11       Impact factor: 23.059

5.  ER81 Expression in Breast Cancers and Hyperplasia.

Authors:  Yuanyuan Wang; Li Wang; Yue Chen; Lin Li; Xuantao Yang; Baolin Li; Shuling Song; Lilin Yang; Yan Hao; Julun Yang
Journal:  Patholog Res Int       Date:  2011-02-27

Review 6.  Apoptosis (the 1992 Frank Rose Memorial Lecture).

Authors:  A H Wyllie
Journal:  Br J Cancer       Date:  1993-02       Impact factor: 7.640

7.  Elevated serum RAS p21 is an independent prognostic factor in metastatic breast cancer.

Authors:  Malgorzata Banys-Paluchowski; Tanja Fehm; Wolfgang Janni; Bahriye Aktas; Peter A Fasching; Sabine Kasimir-Bauer; Karin Milde-Langosch; Klaus Pantel; Brigitte Rack; Sabine Riethdorf; Erich-Franz Solomayer; Isabell Witzel; Volkmar Müller
Journal:  BMC Cancer       Date:  2018-05-08       Impact factor: 4.430

8.  Susceptibility to apoptosis is differentially regulated by c-myc and mutated Ha-ras oncogenes and is associated with endonuclease availability.

Authors:  M J Arends; A H McGregor; N J Toft; E J Brown; A H Wyllie
Journal:  Br J Cancer       Date:  1993-12       Impact factor: 7.640

9.  Expression of ras p21, p53 and c-erbB-2 in advanced breast cancer and response to first line hormonal therapy.

Authors:  S G Archer; A Eliopoulos; D Spandidos; D Barnes; I O Ellis; R W Blamey; R I Nicholson; J F Robertson
Journal:  Br J Cancer       Date:  1995-11       Impact factor: 7.640

10.  Ras protein expression as a marker for breast cancer.

Authors:  Gloria M Calaf; Jorge Abarca-Quinones
Journal:  Oncol Lett       Date:  2016-04-19       Impact factor: 2.967

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.